In vitro and In vivo Trypanocidal Activity of Methanolic Extract of Lantana camara leaves on Trypanosoma brucei in Laboratory Mice

Notice

This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.

Year : 2024 | Volume :02 | Issue : 02 | Page : –
By
vector

Ernest JournaChinedu Ajaegbul,

vector

Ezekiel Kogi,

  1. Assistant Chief Scientific Officer, Department Of Biological Sciences, Ahmadu Bello University Zaria, Zaria, Nigeria
  2. Professor, Department Of Zoology, Ahmadu Bello University, Zaria, Nigeria

Abstract document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_abs_128764’);});Edit Abstract & Keyword

In this study, the methanol extract of Lantana camara leaves were tested for their trypanocidal activity in vitro in a microtitre plate and in vivo using male laboratory mice. Five different concentrations 10mg/ml, 20mg/ml, 30mg/ml, 40mg/ml and 50mg/ml of the extract were prepared and the time taken to immobilize the parasites where recorded. The in vitro results showed that the leave extract at concentrations of 50mg/ml had the most promising trypanocidal activity against Trypanosoma brucei. The LD50 value calculated from the result of the acute toxicity test was found to be 952mg/kg. Based on this result, three different concentrations of the leave extract were prepared namely 200mg/kg, 400mg/kg and 800mg/kg body weight and administered to male laboratory mice in the in vivo studies. The result of the in vivo trypanocidal activity revealed that the methanol extract had no prophylactic effect against Trypanosoma brucei. However, in the curative group there was consistent parasitaemic suppression which was accompanied by prolonged time of survivals especially with treatment doses of 400mg/kg and 800mg/kg body weight daily administered intraperitoneally, even though the number of parasites were not totally wiped out within the 7days of treatment. In the management of trypanosomiasis, the findings in this study are indicative of the trypanocidal potential of Lantana camara. Hence, we recommended that the extract of the leaves as well as other parts of this plant should be further evaluated for trypanocidal activities.

Keywords: Lantana camara, Trypanosoma brucei, Methanol extract, Trypanocidal activity.

[This article belongs to International Journal of Biochemistry and Biomolecule Research (ijbbr)]

How to cite this article:
Ernest JournaChinedu Ajaegbul, Ezekiel Kogi. In vitro and In vivo Trypanocidal Activity of Methanolic Extract of Lantana camara leaves on Trypanosoma brucei in Laboratory Mice. International Journal of Biochemistry and Biomolecule Research. 2024; 02(02):-.
How to cite this URL:
Ernest JournaChinedu Ajaegbul, Ezekiel Kogi. In vitro and In vivo Trypanocidal Activity of Methanolic Extract of Lantana camara leaves on Trypanosoma brucei in Laboratory Mice. International Journal of Biochemistry and Biomolecule Research. 2024; 02(02):-. Available from: https://journals.stmjournals.com/ijbbr/article=2024/view=0

Full Text PDF

References
document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_ref_128764’);});Edit

1. Nayakundi, J., & Pentreath, V. W. (1999). Trypanosomiasis: an overview of the disease in Africa. Parasitology Today, 15(5), 186-190.
2. Brun, R., Blum, J., Chappuis, F., & Burri, C. (2010). Human African trypanosomiasis. The Lancet, 375(9709), 148-159.
3. Van Den Abbeele, J., & Rotureau, B. (2013). Morphology and anatomy of trypanosome transmission by tsetse. International Journal for Parasitology, 43(3-4), 115-121.
4. Franco, J. R., Simarro, P. P., Diarra, A., & Jannin, J. G. (2014). Epidemiology of human African trypanosomiasis. Clinical Epidemiology, 6, 257-275.
5. Coura, J. R., & Borges-Pereira, J. (2010). Chagas disease: 100 years after its discovery. A systemic review. Acta Tropica, 115(1-2), 5-13.
6. Desquesnes, M., Holzmuller, P., Lai, D. H., Dargantes, A., Lun, Z. R., & Jittaplapong, S. (2013). Trypanosoma evansi and surra: A review and perspectives on transmission, epidemiology and control, impact, and zoonotic aspects. BioMed Research International, 2013, 321237.
7. Samdi, S. M., Abenga, J. N., Kalgo, A., Atsanda, N. N., & Usman, A. O. (2008). Epidemiological survey of animal trypanosomosis in northern Nigeria. African Journal of Biomedical Research, 11(3), 229-234.
8. Majekodunmi, A. O., Fajinmi, A., & Welburn, S. C. (2013). Shifting boundaries: Climate change, conflict and cattle diseases in the Nigerian pastoralist system. International Journal of Parasitology, 43(13-14), 1189-1197.
9. Jannin, J., & Cattand, P. (2004). Treatment and control of human African trypanosomiasis. Current Opinion in Infectious Diseases, 17(6), 565-571.
10. Vale, G. A., & Torr, S. J. (2005). User-friendly bait technology for tsetse fly control. Trends in Parasitology, 21(8), 317-321.
11. Brown, R. C., Evans, D. A., & Vickerman, K. (1990). Changes in antigenic variation of Trypanosoma brucei in response to host immune pressure. Parasitology Today, 6(1), 10-15.
12. Babokhov, P., Kazibwe, A. J. N., Dardaillon, I., Thiberge, S., Atouguia, J., & Oliveira, F. (2013). African trypanosomiasis: major advances and challenges in drug development. Future Microbiology, 8(8), 937-951.
13. Fairlamb, A. H., & Horn, D. (2018). Melarsoprol and suramin: Drugs from a bygone era still used for treating sleeping sickness. Parasitology, 145(10), 1317-1326.
14. Fox, J. A., Kohler, P., & Cross, G. A. M. (1993). Antigenic variation in African trypanosomes: Mechanisms and implications for vaccine development. Annual Review of Microbiology, 47, 711-743.
15. Kagira, J. M., & Maina, N. (2007). Occurrence of trypanosomiasis in small ruminants in Kenya: A review. Small Ruminant Research, 70(1), 1.
16. Magez, S., Radwanska, M., Beschin, A., Sekikawa, K., & De Baetselier, P. (1998). Tumor necrosis factor (TNF) is a key mediator in the regulation of experimental Trypanosoma brucei infections. Infection and Immunity, 66(2), 4863-4871
17. Paulneck, S., & Coller, B. S. (2001). Cell adhesion and its role in pathogenesis and treatment of disease. Annual Review of Medicine, 52, 453-470.
18. Barry, J. D. (1997). The role of antigenic variation in the persistence of African trypanosomiasis. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 352(1359), 1307-1314.
19. Strebhardt, K., & Ullrich, A. (2008). Paul Ehrlich’s magic bullet concept: 100 years of progress. Nature Reviews Cancer, 8(6), 473–480.
20. Nok, A., Esievo, K., Longdet, I., Arowosafe, S., Onyenekwe, P., Gimba, C., & Kagbu, J. (1993). Trypanocidal Potentials of Azadirachta indica: In vivo Activity of Leaf Extract against Trypanosoma brucei brucei. Journal of Clinical Biochemistry and Nutrition, 15, 113-118. https://doi.org/10.3164/JCBN.15.113.
21. Ekanem, A. P., & Udoh, F. V. (2009). “Antiplasmodial and trypanocidal activity of ethanolic leaf extracts of Costus afer.” African Journal of Biomedical Research, 12(3), 171-174.
22. Jose, A., Bravo, B., Sauvain, M., Gimenez, A. T., Balanza, E., Serani, L., Laprevote, O., Massiot, G., & Lavaud, C. (2001). “Trypanocidal withanolides and withanolide glycosides from Dunalia brachyacantha.” Journal of Natural Products, 64(6), 720-725.
23. Atawodi, S. E., Bulus, T., Ibrahim, S., Ameh, D. A., Nok, A. J., Mamman, M., & Galadima, M. (2003). In vitro trypanocidal effect of methanolic extract of some Nigerian savannah plants. African Journal of Biotechnology, 2(9), 317-321.
24. Barrett, M. P., & Croft, S. L. (2012). Management of trypanosomiasis and leishmaniasis: Present and future. Expert Review of Anti-infective Therapy, 10(3), 289-291.
25. Nwude, N., Ibrahim, M. A., Aliu, Y. O., & Ogunsusi, R. A. (1983). Traditional Concepts of Animal Disease and Treatment among Fulani Herdsmen in Kaduna State of Nigeria. Pastoral Development Network, 16c.
26. Sasidharan, S., Chen, Y., Saravanan, D., Sundram, K. M., & Yoga Latha, L. (2011). Extraction, isolation, and characterization of bioactive compounds from plants’ extracts. African Journal of Traditional, Complementary, and Alternative Medicines, 8(1), 1-10
27. National Research Council. (2011). Guide for the Care and Use of Laboratory Animals. 8th ed. Washington, DC: The National Academies Press. https://doi.org/10.17226/12910
28. Owolabi, A. T. (1990). Phytochemical and biological studies on selected medicinal plants. Journal of Ethnopharmacology, 28(1), 123-130.
29. Herbert, W. J., & Lumsden, W. H. R. (1976). Trypanosoma brucei: A rapid “matching” method for estimating the host’s parasitemia. Experimental Parasitology, 40(3),427-431. doi: 10.1016/0014-4894(76)90110-7
30. Ene, A. (2014). In vitro and In vivo Antitrypanosomal Effects of Petroleum Ether, Chloroform and Methanol Extracts of Artemisia maritima Linn. British journal of pharmaceutical research, 4, 751-758. https://doi.org/10.9734/BJPR/2014/7631.
31. Chechet, G., Yahaya, J., & Nok, A. (2018). In vitro and in vivo anti-trypanosomal potentials of Afrormosia laxiflora and Khaya senegalensis against Trypanosoma brucei brucei. Nigerian Veterinary Journal. https://doi.org/10.4314/nvj.v39i3.10
32. Ede, S., Aguiyi, J., Omale, S., & Ede, R. (2021). Anti-trypanosomal, antioxidant and antimicrobial activities of the fruiting bodies of Ganoderma lucidum (W. Curt.: Fr) (Ganodermataceae) aqueous extract. Journal of Pharmacy & Bioresources. https://doi.org/10.4314/jpb.v18i3.1.
33. Freiburghaus, F., Kaminsky, R., Nkunya, M. H. H., & Brun, R. (1996). Evaluation of African medicinal plants for their in vitro trypanocidal activity. Journal of Ethnopharmacology, 55(1), 1-11. doi: 10.1016/S0378-8741(96)01458-3
34. Testa, B., & Kramer, S. D. (2008). The biochemistry of drug metabolism–an introduction: Part 4. Reactions of conjugation and their enzymes. Chemistry & Biodiversity, 5(11), 2171-2336.doi: 10.1002/cbdv.200890195
35. Goodman, L. S. & Gilman, A. (1991). Goodman & Gilman’s: The Pharmacological Basis of Therapeutics (8th ed.). McGraw-Hill.
36. Van Reet, N., & Sternberg, J. M. (2018). Trypanosoma brucei interactions with the host immune system: on the road to pathogenicity. Future Microbiology, 13(4), 451-466. doi:10.2217/fmb-2017-0189.
37. Courtin, F., & Ménard, R. (2010). Current and future options for the treatment of human African trypanosomiasis. Nature Reviews Drug Discovery, 9(9), 754-755.
38. Lorke, D. (1983). A new approach to practical acute toxicity testing. Archives of Toxicology, 54(4), 275-287.


Regular Issue Subscription Original Research
Volume 02
Issue 02
Received 06/11/2024
Accepted 21/11/2024
Published 24/12/2024